OVID - Ovid Therapeutics Market Capitalization

Public company logo of Ovid Rx (OVID)

The market value dynamics of Ovid Therapeutics Inc. (OVID), currently 0.47, demonstrate the brand's position as a flawless authority in the therapy of rare brain pathologies. High innovation costs and patent protection create a significant barrier to entry for new players. The business relies on strategic partnerships with biopharmaceutical leaders to develop effective treatments for seizure disorders across various age groups.

Ovid Therapeutics Inc - OVID Market Capitalization (period 07/04/2022 - 11/15/2026)

OVID (Ovid Rx): analytical breakdowns and indicator data

- stock price and consensus target price:
Fundamental company analysis:OVID (Ovid Therapeutics)
Product sample of Ovid Therapeutics Inc

The innovative potential of Ovid Therapeutics Inc. (OVID) is based on the development of unique neurological drugs. The company's valuation is calculated as the product of the current share price and the total number of outstanding shares. This price action reflects the market consensus regarding future cash flows. However, the chart's volatility highlights the sensitivity of the market capitalization to clinical trial results. FDA regulatory risks directly determine the stability of the market value and asset liquidity.

Key competitors

Market Capitalization BIIB (Biogen Idec)|Neurocrine Biosciences Inc - Market Value|regencellbioscience.com - Market Capitalization|Market Capitalization axsome.com AXSM|ACAD: Market Capitalization|Market Value Xenon Pharmaceuticals Inc. (XENE)|Market Value Viking Therapeutics|Market Capitalization SUPN (Supernus Pharma)|Market Capitalization CPRX|DNLI - Market Value|harmonybiosciences.com - Market Valuation|Market Capitalization Biohaven Ltd BHVN|AMLX - Market Value|Market Value TRVI (Trevi Corp)|Praxis Precision Medicines Inc (PRAX) - Market Value|Market Value Anavex Life Sciences (AVXL)|CBLL (CeriBell Inc) - Market Capitalization|Prothena Corporation - Market Valuation|Market Value Alector (ALEC)|Annexon Biosciences Inc. - Market Capitalization|Market Capitalization OMER (Omeros)|Market Capitalization neurogene.com NGNE|AC Immune S.A. - Market Capitalization|VYGR - Market Capitalization|neumoratx.com (NMRA) - Market Value|Market Value Scilex Holding Company (SCLX)|TVGN (Tevogen Bio Holdings Inc.) - Market Capitalization|ACOG: Market Value|Market Capitalization CGTX|Market Capitalization Inhibikase Therapeutics Inc (IKT)|Cassava - Market Valuation|assertiotx.com (ASRT) - Market Value|COYA - Market Value|Market Value VTGN (VistaGen Therapeutics, Inc.)|ABOS: Market Capitalization|CRVO - Market Capitalization|ATHE (alteritytherapeutics.com) - Market Capitalization|Market Valuation clene.com (CLNN)|Market Value pepgen.com (PEPG)|JUNS (Jupiter Neurosciences, Inc.) - Market Value|Market Capitalization RLMD (relmada.com)|Market Capitalization Annovis Bio Inc (ANVS)|GRCE: Market Valuation|Market Capitalization Firefly Neuroscience Inc AIFF|KLTO: Market Capitalization|NeuroSense Therapeutics Ltd - Market Value|Market Valuation RVPH|Market Capitalization MTVA (MetaVia Inc)|Market Value NeurAxis Inc (NRXS)|Helius Medical Technologies Inc. - Market Capitalization|Market Capitalization PASG (Passage Bio Inc.)|Market Capitalization bionomics.com.au NEUP|Minerva Neurosciences Inc - Market Capitalization|ATHA - Market Capitalization|ADXN: Market Capitalization|Alzamend (ALZN) - Market Capitalization|CYCN (cyclerion.com) - Market Capitalization|Protagenic Therapeutics (PTIX) - Market Capitalization|Market Value pasitheaclinics.com (KTTA)|CRGT (Cortigent Inc) - Market Value|Market Capitalization ATXI (Avenue Therapeutics Inc)|Market Value BCLI|Cara Therapeutics Inc - Market Capitalization|Chromocell Therapeutics (CHRO) - Market Valuation|ELYM (Eliem Therapeutics Inc.) - Market Valuation|ITCI - Market Capitalization|Market Value Longboard Pharma|Market Capitalization MRNS (Marinus Pharma)|Market Value NKGen Biotech Inc (NKGN)|NRBO - Market Value|Market Capitalization SAGE (Sage Therapeutics Inc)|Synaptogenix Inc. (SNPX) - Market Value|TRVN: Market Valuation|Market Capitalization vigilneuro.com VIGL|WENA (Anew Medical Inc.) - Market Valuation|Market Valuation Cerevel Therapeutics